Back

Phenotyping the cardiomyopathy spectrum: large-scale analysis of clinical and comorbidity status in the prospective TORCH cohort

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Prognostic modifiers in heart failure Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Christoph Reich

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Early achievement of optimal medical therapy and its impact on survival and morbidity: results from a nationwide implementation science study (BRING-UP-3 HF)
Doctor F. Orso (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Ten-year real-world incidence and prognostic impact of new-onset heart failure after acute coronary syndromes: a population-based analysis of 83,357 patients
Doctor J. Comin-Colet (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Geographic variation in heart failure infrastructure capacity and cardiovascular disease burden in europe: a cross-sectional analysis
Mr S. Pradeep Kundur (London, GB)
Abstract Slides Video
Presentation thumbnail
Gender has impact on survival in post-capillary pulmonary hypertension due to heart failure: insights from the prospective and multicentre PH-HF study
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostic modifiers in heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Prognostic modifiers in heart failure
thumbnail
Congress Session
Advanced phenotyping and risk stratification in cardiomyopathies and myocarditis
thumbnail
Congress Session
Heart failure phenotypes and outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources